Matthew During

Affiliations: 
Univ Auckland, Auckland, Auckland, New Zealand 
Google:
"Matthew During"
Mean distance: 14.07 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Halford JJ, Sperling MR, Arkilo D, et al. (2021) A phase 1b/2a study of soticlestat as adjunctive therapy in participants with developmental and/or epileptic encephalopathies. Epilepsy Research. 174: 106646
Bird LM, Ochoa-Lubinoff C, Tan WH, et al. (2020) The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome. Neurology
Park YE, Penumarthy R, Sun PP, et al. (2020) Platelet-Reactive Antibodies in Patients after Ischaemic Stroke-An Epiphenomenon or a Natural Protective Mechanism. International Journal of Molecular Sciences. 21
Nishi T, Kondo S, Miyamoto M, et al. (2020) Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice. Scientific Reports. 10: 17081
Cogram P, Deacon RMJ, Warner-Schmidt JL, et al. (2019) Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome. Frontiers in Behavioral Neuroscience. 13: 141
Weston M, Kaserer T, Wu A, et al. (2019) Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics. Science Advances. 5: eaaw1567
Niethammer M, Tang CC, Vo A, et al. (2018) Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity. Science Translational Medicine. 10
Kamal T, Green TN, Hearn JI, et al. (2018) -methyl-d-aspartate receptor mediated calcium influx supports in vitro differentiation of normal mouse megakaryocytes but proliferation of leukemic cell lines. Research and Practice in Thrombosis and Haemostasis. 2: 125-138
Patrício MI, Barnard AR, Green AL, et al. (2017) A clinical-grade gene therapy vector for pharmacoresistant epilepsy successfully overexpresses NPY in a human neuronal cell line. Seizure. 55: 25-29
De Silva SR, Barnard AR, Hughes S, et al. (2017) Long-term restoration of visual function in end-stage retinal degeneration using subretinal human melanopsin gene therapy. Proceedings of the National Academy of Sciences of the United States of America
See more...